Neopharm (092730)

Ticker: 092730 Exchange: KOREA


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Lee ju hyoung (이주형) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
219.83
Quantity 38,919 +43.7%
Value ₩4,553,006
Lee ju hyoung (이주형) Representative Director (대표이사) Executive Director
Transaction date
Purchase
Price
180.57
Quantity 23,918
Value ₩2,620,370
IT'S HANBUL&cr;CO., LTD. ((주)잇츠한불) Unclassified position Large shareholder
Transaction date
Purchase
Price
300.85
Quantity 87,296 -11.4%
Value ₩4,793,503
IT'S HANBUL &cr;CO., LTD. ((주)잇츠한불) Unclassified position Large shareholder
Transaction date
Purchase
Price
36,350.00
Quantity 20,000 +0.9%
Value ₩727,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2020-03-02 2020-03-02 B Purchase Lee ju hyoung (이주형)

Representative Director (대표이사)

Executive Director
38,919 +43.7%
219.83
₩4,553,006
38,919 +43.7% 219.83 ₩4,553,006
2020-03-02 2020-02-28 B Purchase Lee ju hyoung (이주형)

Representative Director (대표이사)

Executive Director
23,918
180.57
₩2,620,370
23,918 180.57 ₩2,620,370
2017-12-15 2017-12-13 B Purchase IT'S HANBUL&cr;CO., LTD. ((주)잇츠한불)

Unclassified position

Large shareholder
87,296 -11.4%
300.85
₩4,793,503
87,296 -11.4% 300.85 ₩4,793,503
2017-11-23 2017-11-23 B Purchase IT'S HANBUL &cr;CO., LTD. ((주)잇츠한불)

Unclassified position

Large shareholder
20,000 +0.9%
36,350.00
₩727,000,000
20,000 +0.9% 36,350.00 ₩727,000,000
Explore more

More insider trading research around Neopharm